Highlights: enGen

After finalizing a rebrand to enGen in 2022, the Pittsburgh-based healthtech company vowed to return to market with its suite of innovative solutions, products and services, solidifying its status as a health IT trailblazer. The goal? To deliver best-in-class business outcomes to its clients, and better health outcomes to members.

"Technology isn't just the great enabler of business — technology is the business," emphasized Brian Lucotch, president, enGen. "And the journey to create a differentiated experience for our customers started with a product-centric mindset that empowered enGen's global workforce to rethink the way they deliver technology."

As part of this transformative journey, enGen unveiled innovative products like Predictal, a clinical solution that integrates utilization, case, and disease management in a seamless platform; Providius, a cloud-based solution that optimizes provider maintenance; and intelliGen, a business intelligence solution.

Lucotch highlighted that the company's reentry into the market includes an expansion of its suite of healthtech solutions, and that enGen's evolution has already demonstrated positive impacts on current clients.

"We're purposely bringing business and tech together to best anticipate market needs and accelerate next-generation solutions," he said. "Supporting payers, providers and patients as members go through their health journeys is the purpose of our technology and services, and that is enGen's real differentiator."

Malec furthered the sentiment: "We have a full solution, and when you combine our product-centricity and outcomes-focused mindset, you get differentiators that actively resonate with employees and clients alike."

enGen's progress in 2023 positions it to move confidently into 2024, and to continue delivering on its commitment to transform health care through technology.